Global marketing and registration of finished dosage forms
Turning pharmaceutical possibilities into reality worldwide
We are your perfect partner for an early and global market entry!
We, at TIEFENBACHER PHARMACEUTICALS, strongly believe that our high-quality medicines should be available and affordable for all patients – irrespective of their origin or income level. That´s why we always strive for a global and early market entry for our customers. Thanks to our high excellence and international knowledge in research & development and regulatory affairs, we have already obtained more than 15.000 marketing authorizations in over 80 markets worldwide. Every year we serve over 500 million patients with our generic, valued added, and innovative medicines. And we are working every day to better understand patients’ needs and to address the real-world health-challenges by getting closer than ever to patients.
We, at TIEFENBACHER PHARMACEUTICALS, achieve commercialization and market differentiation through our science innovations and business expertise. While we master the complexity of country-specific regulatory requirements and maintain close contact to the relevant pharmaceutical authorities, our customers can focus on their important brand marketing and save time and money. Outstanding intellectual property guidance (IP) and an efficient supply chain approach are further important drivers for our strong track record in generating first-to-file-dossiers. With TIEFENBACHER, you get expertise, speed and agility, and a healthy dose of pragmatism to drive your pharmaceutical business forward for the benefits of patients around the world.
Tiefenbacher market entry at a glance
Our strong track record in marketing and registration speaks for us
We, at TIEFENBACHER PHARMACEUTICALS are a single-source partner that is able to achieve best results along the whole pharmaceutical value chain – from research and development to registration and commercialization worldwide. By providing access to early innovations and a holstic understanding of the pharmaceutical processess and requirements, we will help you not only got faster but also furhter. We stand for reliability, the highest standards of safety and quality, and a forward-looking approach along the entire pharmaceutical value chain for better healthcare. All our products are manufactured in full compliance with Good Manufacturing Practice (GMP).
15.000+
MAs obtained
>
80+
Countries worldwide
>
150+
Marketing partners on five continents
>
350+
Tender awards in 12 months
>
15.000+
MAs obtained
>
80+
Countries worldwide
>
150+
Marketing partners on five continents
>
350+
Tender awards in 12 months
>
Regulatory Affairs (RA)
>
Frequent first-to-file Generic dossiers
>
First NCE approved
>
100%
Patient-centric
>
Regulatory Affairs (RA)
>
Frequent first-to-file Generic dossiers
>
First NCE approved
>
Patient-centric
>
Our best-in-class medicines based on a patient-centered approach
TIEFENBACHER develops, manufactures, and commercializes generic, value-added, and innovative medicines for patients worldwide
From development to commercialization with speed to market: we provide best-in-class products that meet the need of their markets on a global basis.
Driven by our purpose of bringing high-quality medicines within affordable reach to patients around the world, we provide over 180+ products across various therapeutic categories in 10+ dosage forms including highly potent drugs – and additional medical devices. We are not limited to specific disease areas – whether for widespread or for orphan diseases, we are developing in-house products that address specific therapeutic needs in unique formulations of prescription drugs (Rx) as well as over-the-counter (OTC) medicines – for the benefit of patients worldwide. Furthermore, we are committed for growth and innovation by offering a well-defined and specialized portfolio of highly potent drugs. TIEFENBACHER PHARMACEUTICALS complies with good manufacturing practice (GMP).
Diseases Areas
Oncology
Respiratory
Neuroscience
Cardiovascular, Renal and Metabolism
Immunology, Hepatology and Dermatology
Infectious Diseases
Ophthalmology
Dosages Forms
Tablets
Capsule
Powder
Drops
Inhaler
Transdermal Patches
Eye drops
Additional
Medical Devices
Our global licensing approach for commercialization with speed-to-market
Global availability of our high-quality pharmaceuticals: marketing authorizations in 80+ countries worldwide
Dr. Kristian Ruepp
Managing Director
„Thanks to our international knowledge in R&D and regulatory affairs, we enable our customers to enter global markets as fast as possible – making our high-quality medicines more affordable and more available for patients worldwide."
TIEFENBACHER GROUP: We achieve commercialization and market differentiation to improve patients' lives worldwide
From initial idea to market entry of high-quality pharmaceutical for patients worldwide. We, at TIEFENBACHER PHARMACEUTICALS, are uniquely positioned with the experience, resources, and global expertise in drug commercialization – including highly potent drugs. Through our extensive experience and profound expertise in the international healthcare markets, we are making pharmaceuticals more affordable, more available, and better than before.For more information about our advanced medicines – our portfolio provides over 180+ products across various therapeutic categories in 10+ dosage forms – please contact us by filling out the contact form below and clicking “Send message”, or directly send an email to info@aet.eu. We, at TIEFENBACHER PHARMACEUTICALS, will follow up with you personally as soon as possible.
Find out more on aet.eu
